Concord Wealth Partners Has $2.86 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Concord Wealth Partners trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 27.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,450 shares of the healthcare conglomerate's stock after selling 2,112 shares during the quarter. Concord Wealth Partners' holdings in UnitedHealth Group were worth $2,855,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Financial Management Professionals Inc. grew its stake in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after purchasing an additional 17 shares in the last quarter. Richwood Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after buying an additional 20 shares during the period. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 28.6% in the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after buying an additional 20 shares during the period. Kolinsky Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after purchasing an additional 21 shares during the last quarter. Finally, Retirement Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 1.5%

Shares of UnitedHealth Group stock traded down $4.46 during trading on Thursday, reaching $288.03. 14,738,720 shares of the company were exchanged, compared to its average volume of 7,770,851. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The business has a 50-day moving average price of $308.39 and a 200-day moving average price of $436.45. The firm has a market capitalization of $261.28 billion, a price-to-earnings ratio of 12.06, a P/E/G ratio of 1.42 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the firm earned $6.91 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 3.07%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's payout ratio is presently 37.02%.

Insider Transactions at UnitedHealth Group

In related news, CFO John F. Rex bought 17,175 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer owned 679,493 shares of the company's stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on UNH shares. Wolfe Research reduced their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Oppenheimer dropped their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. Mizuho lowered their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. HSBC reissued a "reduce" rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Finally, Robert W. Baird downgraded UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a research note on Wednesday, June 11th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average price target of $414.35.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.